查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2150230

畜牧疫苗市場報告：趨勢、預測及競爭分析（至2035年）

Livestock Animal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

畜禽疫苗市場

全球畜牧疫苗市場前景廣闊，活疫苗和去活化疫苗市場均蘊藏著巨大機會。預計全球畜牧疫苗市場規模將從2027年的66億美元成長至2035年的91億美元，2027年至2035年的複合年成長率（CAGR）為3.9%。推動該市場成長的關鍵因素包括：對健康牲畜的需求不斷成長、對動物預防保健的日益重視以及先進獸用疫苗的廣泛應用。

  • 根據 Lucintel 的預測，由於養豬業的增加和跨境動物疾病爆發風險的上升，豬疫苗預計在預測期內將呈現最高的成長率。
  • 就疫苗類型而言，傳統去活化疫苗被認為更安全，因此預計在預測期內將呈現更高的成長率。
  • 從區域來看，亞太地區預計將在預測期內呈現最高的成長率，這主要得益於畜牧業的擴張以及對動物健康和福利投資的增加。

畜牧疫苗市場新趨勢

預計2025年至2027年，畜牧疫苗市場將重點放在與畜牧生產力相關的疾病預防、監測和控制。 Lucintel基於畜牧養殖密度不斷提高、對更安全動物產品的需求日益成長以及獸用疫苗投資不斷增加等因素預測了這一趨勢。市場將青睞那些有助於減少抗生素依賴、同時支持實施綜合畜牧疾病預防和控制方案的疫苗。

  • 預防性健康管理：在控制牲畜疾病方面，疫苗接種優先於治療。疾病預防是控制抗生素抗藥性和其他通用感染疾病的有效途徑。隨著跨國動物疫病威脅的日益加劇，許多國家正在實施大規模的禽類和豬類疫苗接種計畫。從經濟角度來看，採取預防措施防止疾病傳播是明智之舉，因為預防疾病傳播的成本低於疾病和貿易限制造成的經濟損失。
  • 疫苗配方：重點在於提高疫苗穩定性、冷鏈管理和現場使用性。在許多偏遠地區，疫苗接種和接種途徑受限，但提高疫苗穩定性可以擴大牲畜疾病預防的範圍。
  • 疫苗有效性監測：改善牲畜疾病的診斷檢測將有助於確定特定疾病的疫苗接種範圍。到2025年，多家獸醫診斷實驗室將開始向獸醫提供動物病原體的下一代基因定序。這將使獸醫能夠更深入地了解跨境動物疾病的預防範圍。
  • 競爭激烈的組合疫苗和平台疫苗：人們對下一代組合疫苗寄予厚望。製造商正在投資基於載體和重組技術的疫苗，同時也開發多價疫苗。未來幾年將有望看到能夠抵禦多種病原體的疫苗。這些平台將使疫苗製造商能夠更靈活地應對區域差異。
  • 擴大以地區為基礎疫苗和生技藥品生產：許多高所得國家和主要供應國正在投資建立本地生技藥品生產能力，以彌補供應缺口。非洲和亞洲的一些國家也正在投資建立區域疫苗生產能力。這些投資可望增加供應量，加快交付速度以滿足當地需求，並拓寬疫苗選擇範圍以滿足當地需求。

這種成長將與牲畜的健康和福祉密切相關，而非疫苗本身。傳統上，牲畜健康和福利的差異與農業生產力的差異密切相關。未來五年，如果支持疫苗及相關物資運輸的基礎設施發展，開發中國家的牲畜健康和生產力有望得到改善。

畜牧疫苗市場近期趨勢

隨著畜牧疾病監測體系的加強以及畜牧業監管和競爭的加劇，預計未來幾年畜牧疫苗市場的投資將進一步成長。因此，Lucintel預測，投資將集中在重組技術上。此外，疫苗生產設施和可靠的冷鏈配送系統也將至關重要。

  • 生產商：勃林格殷格翰動物保健公司（BI）決定投資 1 億歐元在法國建造一座新的牲畜疫苗生產廠（2025 年 1 月）。
  • 合作關係：2025 年 2 月，默沙東動物保健公司和 Hester Biosciences 公司宣佈建立合作關係，共同在印度銷售動物疫苗。
  • 創新：碩騰公司已擴展其面向美國酪農的產品線（2025年），其中包括一系列感測器和診斷設備。這標誌著畜牧健康和疫苗市場正在持續轉變，市場更加重視能夠實際改善畜牧健康和生產力的產品，而非僅僅追求品牌。
  • 加速政策因應：歐盟委員會批准將禽流感疫苗的使用範圍擴大至2025年，顯示歐盟正在加強對高影響感染疾病疫情的政策因應。這項批准也顯示監管機構在禽流感疫苗的使用上變得更加積極主動。這些潛在的政策和監管變化將有助於預防禽流感，並影響家禽及家禽產品的國際貿易格局。
  • 生產在地化：印度政府透過提供補貼和規範2025年的採購，促進了獸用生技藥品的本地生產。預計未來幾年，印度市場將能夠實現獸用生技藥品的在地化生產，這可能會影響對進口的依賴，並加劇價格競爭。

獸醫學的進步使得動物疾病的計劃性預防成為可能。動物疫苗生產商將圍繞疫苗供應的可靠性、易用性以及證明疫苗有效性能夠提高盈利能力的經驗數據展開競爭。針對動物疫苗的特定法規將要求企業在目標地區建立業務。提高農作物和牲畜生產力以及減少抗生素使用的需求預計將進一步提升人們對牛的關注度。未來五年，疫苗將成為動物用藥品產品組合的核心組成部分。在動物用藥品整合疫苗、診斷和/或監測技術的企業將最具競爭力。

目錄

第1章摘要整理

第2章 市場概覽

  • 背景與分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章：全球畜牧疫苗市場：按類型分類

  • 吸引力分析：按類型
  • 減毒活疫苗
  • 去活化疫苗
  • 其他

第5章：全球畜牧疫苗市場：依應用領域分類

  • 吸引力分析：依目的
  • 豬
  • 牛
  • 家禽
  • 其他

第6章 區域分析

第7章：北美畜牧疫苗市場

  • 北美畜牧疫苗市場：按類型分類
  • 北美畜牧疫苗市場：依應用領域分類
  • 美國牲畜疫苗市場
  • 加拿大牲畜疫苗市場
  • 墨西哥牲畜疫苗市場

第8章：歐洲畜牧疫苗市場

  • 歐洲畜牧疫苗市場：按類型分類
  • 歐洲畜牧疫苗市場：依應用領域分類
  • 德國畜牧疫苗市場
  • 法國牲畜疫苗市場
  • 義大利牲畜疫苗市場
  • 西班牙牲畜疫苗市場
  • 英國牲畜疫苗市場

第9章：亞太地區畜牧疫苗市場

  • 亞太地區畜牧疫苗市場：按類型分類
  • 亞太地區畜牧疫苗市場：依應用領域分類
  • 中國的畜牧疫苗市場
  • 印度牲畜疫苗市場
  • 日本畜禽疫苗市場
  • 韓國畜牧疫苗市場
  • 印尼牲畜疫苗市場

第10章：世界其他地區的牲畜疫苗市場

  • 其他區域畜牧疫苗市場：按類型
  • 其他地區的畜牧疫苗市場：依應用領域分類
  • 中東牲畜疫苗市場
  • 南美洲牲畜疫苗市場
  • 非洲牲畜疫苗市場

第11章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析
  • 市佔率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 新趨勢：全球畜牧疫苗市場
  • 戰略分析

第13章：價值鏈中關鍵企業的公司概況

  • 競爭分析概述
  • Merck
  • Boehringer Ingelheim
  • Zoetis
  • Ceva
  • Elanco
  • CAHIC
  • Jinyu Bio-Technology
  • HVRI
  • Ringpu Biology
  • Yebio

第14章附錄

Livestock Animal Vaccine Market

The future of the global livestock animal vaccine market looks promising with opportunities in the live attenuated vaccine and inactivated vaccine markets. The global livestock animal vaccine market is expected to reach an estimated $9.1 billion by 2035 from $6.6 billion in 2027 with a CAGR of 3.9% from 2027 to 2035. The major drivers for this market are the increasing demand for disease free livestock, the rising focus on preventive animal healthcare, and the growing adoption of advanced veterinary vaccines.

  • Lucintel forecasts that, within the application category, pig is expected to witness the highest growth over the forecast period due to more pig farming and greater potential for the spread of transboundary animal diseases.
  • Within the type category, inactivated vaccine is expected to witness higher growth over the forecast period due to traditional inactivated vaccines are safer.
  • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to rise of animal husbandry and increased investment in animal health and welfare.

Emerging Trends in Livestock Animal Vaccine Market

The focus of the livestock vaccine market is expected to be on prevention, surveillance and control of livestock productivity from 2025 to 2027. Lucintel anticipates this trend based upon the increase in livestock unit densities, increasing demands for safe animal food products and the growing investment in veterinary vaccines. The market prefers vaccines that help accomplish the goal of reducing the dependence on antibiotics while helping to implement integrated prevention and control programs of livestock diseases.

  • Preventive Health Management: To control livestock diseases, vaccination is preferred over treatment; prevention of disease is an effective approach to control antimicrobial resistance and other zoonotic infections. Due to the increasing threat of transboundary animal diseases, many countries have expansive vaccination programs against avian and swine diseases. From an economic perspective, it is prudent to implement preventive measures to stop the spread of diseases as the cost of preventing the spread of diseases is less than the economic loss caused by diseases and trade restrictions.
  • Vaccine Formulations: There is focus in improving the stability, Cold Chain and Field readiness of vaccines. While many remote areas are difficult to access and vaccinate, improving stability of vaccines will increase the scope of prevention of livestock diseases.
  • Vaccine Efficacy Surveillance: Improving the diagnostic tests for livestock diseases will further help in determining the scope of vaccination against particular diseases. In 2025, several veterinary diagnostic laboratories began offering next generation genetic sequencing of animal pathogens to veterinarians. This will help veterinarians to better understand the scope of prevention of trans-boundary animal diseases.
  • Competitor Combination and Platform Vaccines: Expectations for next generation combination vaccines are increasing. Manufacturers are also investing in vector-based and recombinant technology as well as developing multivalent vaccines. In the next few years, expect to see vaccines protecting against multiple pathogens. These platforms allow vaccine manufacturers to be more nimble in the face of regional variation.
  • A Greater Vaccine and Biologics Production on A Regional Basis: Many high-income countries and major suppliers are also investing to build local biologics capacity to address gaps in supply. Several countries in Africa and Asia are also investing to build regional vaccine production capacities. These investments should increase supply, improve the timeliness of supply to meet local demand, and improve the range of vaccine options to meet local needs.

Growth will be related to the health and wellness of livestock more than the vaccines themselves. Traditionally, the gaps in livestock health and wellness have correlated to gaps in the productivity of the agriculture sector. In the next five years, improvements in the infrastructure to support the movement of vaccines and related supplies should improve the health and productivity of livestock in the developing world

Recent Developments in the Livestock Animal Vaccine Market

The next few years should see more investments in the livestock vaccine market as the surveillance of livestock diseases has increased, and the cattle industry has become more regulatory and competitive. As a result, Lucintel expects the focus of the investments to be on recombinant technologies. In addition, facilities to manufacture vaccines and a reliable cold chain distribution system will be key.

  • Manufacturing: Boehringer Ingelheim Vetmedica GmbH (BI) committed €100 million to construct a new livestock vaccine manufacturing plant in France (January 2025).
  • Partnership: In February 2025, MSD Animal Health and Hester Biosciences announced a collaboration to jointly market animal vaccines in India.
  • Innovation: Zoetis expanded its product offerings for U.S. dairy farmers, including a suite of sensors and diagnostics (2025). This represents the continued shift in the livestock health and vaccination market, to value more products which result in measurable improvements in livestock health and productivity as opposed to products which are simply branded.
  • Faster Policy Responses: The European Commission's 2025 approval of a broader range of applications for the avian influenza vaccine indicated that the EU was strengthening its policy response to high-impact outbreaks. The approval also signaled that regulatory bodies are becoming more receptive to the use of avian influenza vaccines. The potential changes to policy and regulation are likely to enable the prevention of avian influenza and shape international trade in poultry and poultry products.
  • Localization of Production: The Indian government subsidized and/or controlled the purchase of veterinary biologicals in 2025, thereby promoting local manufacturing. It is expected that local production of veterinary biologicals will be available in the Indian market in the coming years, which is likely to impact import dependency and increase price competition.

Advancements in veterinary medicine are enabling planned prevention of animal diseases. Manufacturers of animal vaccines will compete based on the reliability of vaccine supply, convenience of administration, and evidence that the vaccine impact improves profit margin. Company-specific regulation of animal vaccines will require that companies have a presence in target geographies. Cattle are expected to gain increased focus due to the need to increase crop and livestock productivity and reduce the use of antibiotics. For the next five years, vaccines will be a core component of the animal health portfolio. Companies integrating animal health vaccines, diagnostics and/or monitoring will be the most competitive.

Strategic Growth Opportunities in the Livestock Animal Vaccine Market

Livestock vaccines are in an extended market cycle as surveillance of infectious diseases of livestock has improved. Biosecurity spending has also trended upwards. Past trends have shown that farmers prefer to invest in vaccination to prevent diseases rather than spend on medicines to control or eradicate diseases. Between 2024 and 2026, factors including climate change, and expansion in protein production create an opportunity for livestock vaccines. During this period, Lucintel expects that the market trend would shift to prioritization of regional and advanced supply of veterinary vaccines.

  • Disease Vaccines: Transboundary animal diseases like African swine fever (ASF) and influenzas offer market potential for vaccines. As of January 2025, ASF was reported to be over 60 countries as per the World Organization for Animal Health (WOAH).
  • Precision Livestock: Continuous and real time monitoring of livestock can facilitate the use of customized and differentiated vaccination services. The European Commission's proposal for a regulation on the use of electronic identification and other technologies for the monitoring of livestock entered into force in June 2025.
  • Aquaculture and Other Protein Sources: Increasing livestock and fish production creates additional opportunities and needs for livestock and fish vaccination. As of February 2025, the UN Food and Agriculture Organization (FAO) estimated that the global aquaculture production was approximately 85 million tons.
  • Thermostable and Adjuvanted Vaccines: Vaccines tolerant to transport interruptions can reach smallholder and remote farmers. Gavi reported in 2025 that that logistics to maintain vaccine cold chain can account for 80% of the vaccine cost. Long-lasting vaccines can solve the problem of vaccine waste and increase vaccine coverage.
  • Regional Manufacturing and Licensing: Rapid response manufacturing contracts and other joint ventures can address the needs of emerging markets. It was reported in 2026 that the livestock population of India was 500 million. Regional manufacturing of vaccines will also allow vendors to gain public and private contracts for the supply of vaccines in the area in the next 3-5 years.

Demand for veterinary vaccines is expected to increase in the coming years. More end-users are requesting vaccines beyond preventive measures. There is an increased interest for vaccines to prevent specific diseases. Lead times for regulatory approvals for emergency vaccines is expected to decrease. Companies that can produce farm-relevant vaccines and combine it with a strong cold chain will have an edge in the market.

Livestock Animal Vaccine Market Drivers and Challenges

Rising threats from pathogens and increased focus on sustainable development in the livestock sector presents a potential market for vaccines. There is an increasing emphasis on improved livestock health, reduction in livestock mortality and the judicious use of antimicrobials. Novel biotechnologies facilitate the development of vaccines for complex pathogens. The focus on Harmonization of Veterinary regulations, together with the reforms and modernization of the transportation and Cold Chain Infrastructure provide opportunities for equal distribution of vaccines. According to Lucintel, the next three to five years are expected to witness continued transitions in the livestock production systems and in the required levels of biosecurity. This is expected to shape the market and industry competition structure.

The factors responsible for driving this market include:

  • Increasing Customer Demand: Increased global population, changing dietary preferences and the resultant accelerated growth in meat, egg and dairy production create an imperative for improving the productivity and health of livestock. The FAO projects that by 2050, all components of world agriculture including livestock will need to increase its productivity.
  • New Technologies: Recent innovations in vaccine technologies including the use of mRNA and vectors has shortened the time required to develop vaccines and improved the type and level of protection afforded by vaccines. Simultaneously, improvements in genomic sequencing, surveillance, and other monitoring technologies have facilitated the real-time detection and tracking of pathogens. Between 2021 and 2025, rapid improvements in technologies, especially in human health, increased interest in the development and use of similar platforms in the veterinary field. The use of adjuvants improved the formulation of multivalent, thermostable, and single-dose vaccines. Better diagnostic and vaccination technologies and improved veterinary public health emergency responses will be achieved in the next three to five years.
  • Regulatory Changes: The growing interest in increasing food and veterinary public health through the free movement of commodities and trade has promoted countries to strengthen their legislative and regulatory frameworks to protect the health of animals under their control and facilitate the free movement of commodities and trade. In the next three to five years, increased harmonization of veterinary public health regulatory standards is expected to positively impact the veterinary biopharmaceutical industry, especially for the control of transboundary animal diseases of poultry, swine and cattle.
  • Sustainability: Sustainability in livestock production relies on the optimization of numerous factors, including feed, energy, water and other resources. Unnecessary losses due to disease increase production costs. Preventative measures, including vaccination, play an important role in enhancing sustainability. The World Health Organization (WHO) classifies antimicrobial resistance as a critical human health issue. Consequently, the goal of the agriculture industry is to integrate practices which reduce the reliance on antimicrobials. Integrating vaccination programs in livestock production helps to optimize resource use. Reductions in meat and milk production losses increase farm efficiency and reduce greenhouse gas emissions. Within the next three to five years, primarily due to the increasing concern for the protection of the environment and the welfare of farm animals, preventive vaccination programs are expected to gain greater industry acceptance.
  • Manufacturing: The increasing geographical concentration of the biologics industry, coupled with the sophistication of the bioprocessing, formulation and cold chain technologies, continues to favor the vaccine industry. In 2025, the goal of many biologics manufacturers was to build local production capacities in developing countries to improve access to vaccines. The lack of economies of scale in the vaccine manufacturing industry, coupled with the investment needed to implement advanced processes and quality control, prevents reduction in the cost of vaccines. Within the vaccine industry, automation and information technologies facilitate the rapid response required for the production of vaccines against emerging infectious diseases. These advancements are expected to benefit primarily small and medium-size farming operations.

The challenges facing this market include:

  • Cold-Chain and Distribution: Many vaccines lose potency during transport and storage due to unstable electricity supply. Further, veterinary services may be unavailable or long distances away. Rural areas of developing nations have the greatest need for improved vaccine supply and distribution. Improved veterinary distribution and storage of vaccines, as well as the development of vaccines that are more temperature stable and easier to transport, will contribute to the rural areas of developing countries where the need is greatest.
  • Production and Development: The cost and length of time required for the development and production of veterinary vaccines, as compared to human vaccines, has left a significant number of potential vaccines unexplored and undeveloped. The cost and time required to complete the development and production of multivalent vaccines, as compared to monovalent vaccines, has created a significant cost barrier to completing the development and production of vaccines to control economically important livestock diseases. In the upcoming years, it is expected that costs and time required for development of veterinary biologics would continue to stifle innovation. Limited resources would be directed toward those diseases that primarily affect high-income livestock markets.
  • Variability of Disease and Farmer Acceptance of Veterinary Vaccines: Mutation of pathogens, variability of strains of a particular pathogen, inadequate diagnostic tests, and inconsistent compliance of farmers, can limit the efficacy of veterinary vaccines. Cost and the perception of the benefits of vaccination, awareness, and the labor required for their administration, can also affect the acceptance of veterinary vaccination. In 2025, several outbreaks of avian influenza and other transboundary animal diseases, illustrate the rapid changes in the high-health status of the animal populations and the disruption of international trade. It is expected that within the next 3 to 5 years, the veterinary services sector would have established adequate veterinary services and improved surveillance to increase the acceptance of vaccination by farmers.

There is considerable potential for the growth of the animal vaccination market as a consequence of reduction in the prevalence of animal diseases, increase in agricultural production, and improving the sustainability of the farming industry. Improvement in biotechnology, and partnerships between regulatory agencies, would facilitate the increase in supply of animal vaccines. Increasing demand from emerging countries and improved economy of large animal farming would increase the acceptance of animal vaccination. Advances in distribution and collaboration by governments and the veterinary and farming professions would facilitate the use of veterinary vaccines. Of major concern is the availability of affordable veterinary vaccines.

List of Livestock Animal Vaccine Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies livestock animal vaccine market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the livestock animal vaccine market companies profiled in this report include-

  • Merck
  • Boehringer Ingelheim
  • Zoetis
  • Ceva
  • Elanco

Livestock Animal Vaccine Market by Segment

The study includes a forecast for the global livestock animal vaccine market by type, application, and region.

Livestock Animal Vaccine Market by Type [Value ($B) from 2019 to 2035]:

  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Others

Livestock Animal Vaccine Market by Application [Value ($B) from 2019 to 2035]:

  • Pig
  • Cattle
  • Poultry
  • Others

Livestock Animal Vaccine Market by Region [Value ($B) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Livestock Animal Vaccine Market

Stricter policies on the control of animal diseases have created opportunities for the development of the livestock vaccines industry in different regions of the world. The period 2025-2027 is expected to see increased vaccination efforts against avian influenza, foot-and-mouth disease and African swine fever. Based on Lucintel's research, vaccination policy will continue to be influential.

  • United States: The US Department of Agriculture (USDA) announced a series of policies worth about $1 billion in February 2025 to address H5N1. The USDA's policies promoted the enhanced biosecurity of farms and provided financial assistance to farmers to help cover the costs of testing for the presence of zoonotic diseases on farm premises. The USDA also funded on-farm measures to control zoonotic diseases. It is expected that in the next 3-5 years, these policies would promote the development and implementation of cattle, poultry and swine vaccination programs.
  • China: China is implementing its 2022-2025 National Plan to control Animal Epidemics. As reported by China's Department of Agriculture, Foot and Mouth Disease (FMD) vaccination was obligatory for all livestock. Other diseases included African Swine Fever and Highly Pathogenic Avian Influenza. The above-mentioned policies facilitate improving the local livestock vaccination industries in China.
  • Germany: Foot-and-Mouth: Following the confirmation of FMD cases in Brandenburg in January 2025, Germany implemented movement controls and actively discussed emergency vaccination within the framework of the EU. FMD has not been reported in Germany since 1988. While vaccination banks, laboratory diagnostics and other preventative measures will be enhanced, efforts to improve trace-out and transit controls for livestock will continue.
  • India: Free Veterinary Services: The National Animal Disease Control Program continued free veterinary services against FMD and Brucellosis in 2025. New localized poultry outbreaks and continued government commitments to supply the services further strengthened the demand for and supported the production of livestock vaccines in India.
  • Japan: Avian Influenza: During the 2024-2025 school year, Japan experienced multiple cases of highly pathogenic avian influenza in poultry and imposed quarantines and bird movement restrictions. Similar events in previous years strengthened Japan's commitment to improving avian influenza vaccine research, development and production.

Features of the Global Livestock Animal Vaccine Market

  • Market Size Estimates: livestock animal vaccine market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: livestock animal vaccine market size by type, application, and region in terms of value ($B).
  • Regional Analysis: livestock animal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the livestock animal vaccine market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the livestock animal vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the livestock animal vaccine market by type (live attenuated vaccine, inactivated vaccine, and others), application (pig, cattle, poultry, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Livestock Animal Vaccine Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Live Attenuated Vaccine : Trends and Forecast 2019 to 2035
  • 4.4 Inactivated Vaccine : Trends and Forecast 2019 to 2035
  • 4.5 Others : Trends and Forecast 2019 to 2035

5. Global Livestock Animal Vaccine Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Pig : Trends and Forecast 2019 to 2035
  • 5.4 Cattle : Trends and Forecast 2019 to 2035
  • 5.5 Poultry : Trends and Forecast 2019 to 2035
  • 5.6 Others : Trends and Forecast 2019 to 2035

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Livestock Animal Vaccine Market by Region

7. North American Livestock Animal Vaccine Market

  • 7.1 Overview
  • 7.2 North American Livestock Animal Vaccine Market by Type
  • 7.3 North American Livestock Animal Vaccine Market by Application
  • 7.4 The United States Livestock Animal Vaccine Market
  • 7.5 Canadian Livestock Animal Vaccine Market
  • 7.6 Mexican Livestock Animal Vaccine Market

8. European Livestock Animal Vaccine Market

  • 8.1 Overview
  • 8.2 European Livestock Animal Vaccine Market by Type
  • 8.3 European Livestock Animal Vaccine Market by Application
  • 8.4 German Livestock Animal Vaccine Market
  • 8.5 French Livestock Animal Vaccine Market
  • 8.6 Italian Livestock Animal Vaccine Market
  • 8.7 Spanish Livestock Animal Vaccine Market
  • 8.8 The United Kingdom Livestock Animal Vaccine Market

9. APAC Livestock Animal Vaccine Market

  • 9.1 Overview
  • 9.2 APAC Livestock Animal Vaccine Market by Type
  • 9.3 APAC Livestock Animal Vaccine Market by Application
  • 9.4 Chinese Livestock Animal Vaccine Market
  • 9.5 Indian Livestock Animal Vaccine Market
  • 9.6 Japanese Livestock Animal Vaccine Market
  • 9.7 South Korean Livestock Animal Vaccine Market
  • 9.8 Indonesian Livestock Animal Vaccine Market

10. ROW Livestock Animal Vaccine Market

  • 10.1 Overview
  • 10.2 ROW Livestock Animal Vaccine Market by Type
  • 10.3 ROW Livestock Animal Vaccine Market by Application
  • 10.4 Middle Eastern Livestock Animal Vaccine Market
  • 10.5 South American Livestock Animal Vaccine Market
  • 10.6 African Livestock Animal Vaccine Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Type
    • 12.2.2 Growth Opportunity by Application
  • 12.3 Emerging Trends in the Global Livestock Animal Vaccine Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 Merck
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Boehringer Ingelheim
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Zoetis
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Ceva
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Elanco
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 CAHIC
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Jinyu Bio-Technology
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 HVRI
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Ringpu Biology
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Yebio
    • Company Overview
    • Livestock Animal Vaccine Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Livestock Animal Vaccine Market
  • Figure 2.1: Usage of Livestock Animal Vaccine Market
  • Figure 2.2: Classification of the Global Livestock Animal Vaccine Market
  • Figure 2.3: Supply Chain of the Global Livestock Animal Vaccine Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Livestock Animal Vaccine Market
  • Figure 4.1: Global Livestock Animal Vaccine Market by Type in 2019, 2026, and 2035
  • Figure 4.2: Trends of the Global Livestock Animal Vaccine Market ($B) by Type
  • Figure 4.3: Forecast for the Global Livestock Animal Vaccine Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Live Attenuated Vaccine in the Global Livestock Animal Vaccine Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Inactivated Vaccine in the Global Livestock Animal Vaccine Market (2019-2035)
  • Figure 4.6: Trends and Forecast for Others in the Global Livestock Animal Vaccine Market (2019-2035)
  • Figure 5.1: Global Livestock Animal Vaccine Market by Application in 2019, 2026, and 2035
  • Figure 5.2: Trends of the Global Livestock Animal Vaccine Market ($B) by Application
  • Figure 5.3: Forecast for the Global Livestock Animal Vaccine Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Pig in the Global Livestock Animal Vaccine Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Cattle in the Global Livestock Animal Vaccine Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Poultry in the Global Livestock Animal Vaccine Market (2019-2035)
  • Figure 5.7: Trends and Forecast for Others in the Global Livestock Animal Vaccine Market (2019-2035)
  • Figure 6.1: Trends of the Global Livestock Animal Vaccine Market ($B) by Region (2019-2026)
  • Figure 6.2: Forecast for the Global Livestock Animal Vaccine Market ($B) by Region (2027-2035)
  • Figure 7.1: Trends and Forecast for the North American Livestock Animal Vaccine Market (2019-2035)
  • Figure 7.2: North American Livestock Animal Vaccine Market by Type in 2019, 2026, and 2035
  • Figure 7.3: Trends of the North American Livestock Animal Vaccine Market ($B) by Type (2019-2026)
  • Figure 7.4: Forecast for the North American Livestock Animal Vaccine Market ($B) by Type (2027-2035)
  • Figure 7.5: North American Livestock Animal Vaccine Market by Application in 2019, 2026, and 2035
  • Figure 7.6: Trends of the North American Livestock Animal Vaccine Market ($B) by Application (2019-2026)
  • Figure 7.7: Forecast for the North American Livestock Animal Vaccine Market ($B) by Application (2027-2035)
  • Figure 7.8: Trends and Forecast for the United States Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European Livestock Animal Vaccine Market (2019-2035)
  • Figure 8.2: European Livestock Animal Vaccine Market by Type in 2019, 2026, and 2035
  • Figure 8.3: Trends of the European Livestock Animal Vaccine Market ($B) by Type (2019-2026)
  • Figure 8.4: Forecast for the European Livestock Animal Vaccine Market ($B) by Type (2027-2035)
  • Figure 8.5: European Livestock Animal Vaccine Market by Application in 2019, 2026, and 2035
  • Figure 8.6: Trends of the European Livestock Animal Vaccine Market ($B) by Application (2019-2026)
  • Figure 8.7: Forecast for the European Livestock Animal Vaccine Market ($B) by Application (2027-2035)
  • Figure 8.8: Trends and Forecast for the German Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC Livestock Animal Vaccine Market (2019-2035)
  • Figure 9.2: APAC Livestock Animal Vaccine Market by Type in 2019, 2026, and 2035
  • Figure 9.3: Trends of the APAC Livestock Animal Vaccine Market ($B) by Type (2019-2026)
  • Figure 9.4: Forecast for the APAC Livestock Animal Vaccine Market ($B) by Type (2027-2035)
  • Figure 9.5: APAC Livestock Animal Vaccine Market by Application in 2019, 2026, and 2035
  • Figure 9.6: Trends of the APAC Livestock Animal Vaccine Market ($B) by Application (2019-2026)
  • Figure 9.7: Forecast for the APAC Livestock Animal Vaccine Market ($B) by Application (2027-2035)
  • Figure 9.8: Trends and Forecast for the Japanese Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW Livestock Animal Vaccine Market (2019-2035)
  • Figure 10.2: ROW Livestock Animal Vaccine Market by Type in 2019, 2026, and 2035
  • Figure 10.3: Trends of the ROW Livestock Animal Vaccine Market ($B) by Type (2019-2026)
  • Figure 10.4: Forecast for the ROW Livestock Animal Vaccine Market ($B) by Type (2027-2035)
  • Figure 10.5: ROW Livestock Animal Vaccine Market by Application in 2019, 2026, and 2035
  • Figure 10.6: Trends of the ROW Livestock Animal Vaccine Market ($B) by Application (2019-2026)
  • Figure 10.7: Forecast for the ROW Livestock Animal Vaccine Market ($B) by Application (2027-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African Livestock Animal Vaccine Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Livestock Animal Vaccine Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Livestock Animal Vaccine Market (2026)
  • Figure 12.1: Growth Opportunities for the Global Livestock Animal Vaccine Market by Type
  • Figure 12.2: Growth Opportunities for the Global Livestock Animal Vaccine Market by Application
  • Figure 12.3: Growth Opportunities for the Global Livestock Animal Vaccine Market by Region
  • Figure 12.4: Emerging Trends in the Global Livestock Animal Vaccine Market

List of Tables

  • Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the Livestock Animal Vaccine Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Livestock Animal Vaccine Market by Region
  • Table 1.3: Global Livestock Animal Vaccine Market Parameters and Attributes
  • Table 3.1: Trends of the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 3.2: Forecast for the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 4.1: Attractiveness Analysis for the Global Livestock Animal Vaccine Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 4.4: Trends of Live Attenuated Vaccine in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 4.5: Forecast for Live Attenuated Vaccine in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 4.6: Trends of Inactivated Vaccine in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 4.7: Forecast for Inactivated Vaccine in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 4.8: Trends of Others in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 4.9: Forecast for Others in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 5.1: Attractiveness Analysis for the Global Livestock Animal Vaccine Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 5.4: Trends of Pig in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 5.5: Forecast for Pig in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 5.6: Trends of Cattle in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 5.7: Forecast for Cattle in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 5.8: Trends of Poultry in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 5.9: Forecast for Poultry in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 5.10: Trends of Others in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 5.11: Forecast for Others in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Livestock Animal Vaccine Market (2019-2026)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Livestock Animal Vaccine Market (2027-2035)
  • Table 7.1: Trends of the North American Livestock Animal Vaccine Market (2019-2026)
  • Table 7.2: Forecast for the North American Livestock Animal Vaccine Market (2027-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Livestock Animal Vaccine Market (2019-2026)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Livestock Animal Vaccine Market (2027-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Livestock Animal Vaccine Market (2019-2026)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Livestock Animal Vaccine Market (2027-2035)
  • Table 7.7: Trends and Forecast for the United States Livestock Animal Vaccine Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Livestock Animal Vaccine Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Livestock Animal Vaccine Market (2019-2035)
  • Table 8.1: Trends of the European Livestock Animal Vaccine Market (2019-2026)
  • Table 8.2: Forecast for the European Livestock Animal Vaccine Market (2027-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European Livestock Animal Vaccine Market (2019-2026)
  • Table 8.4: Market Size and CAGR of Various Type in the European Livestock Animal Vaccine Market (2027-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European Livestock Animal Vaccine Market (2019-2026)
  • Table 8.6: Market Size and CAGR of Various Application in the European Livestock Animal Vaccine Market (2027-2035)
  • Table 8.7: Trends and Forecast for the German Livestock Animal Vaccine Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Livestock Animal Vaccine Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Livestock Animal Vaccine Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Livestock Animal Vaccine Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Livestock Animal Vaccine Market (2019-2035)
  • Table 9.1: Trends of the APAC Livestock Animal Vaccine Market (2019-2026)
  • Table 9.2: Forecast for the APAC Livestock Animal Vaccine Market (2027-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Livestock Animal Vaccine Market (2019-2026)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Livestock Animal Vaccine Market (2027-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Livestock Animal Vaccine Market (2019-2026)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Livestock Animal Vaccine Market (2027-2035)
  • Table 9.7: Trends and Forecast for the Japanese Livestock Animal Vaccine Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Livestock Animal Vaccine Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Livestock Animal Vaccine Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Livestock Animal Vaccine Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Livestock Animal Vaccine Market (2019-2035)
  • Table 10.1: Trends of the ROW Livestock Animal Vaccine Market (2019-2026)
  • Table 10.2: Forecast for the ROW Livestock Animal Vaccine Market (2027-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Livestock Animal Vaccine Market (2019-2026)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Livestock Animal Vaccine Market (2027-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Livestock Animal Vaccine Market (2019-2026)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Livestock Animal Vaccine Market (2027-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Livestock Animal Vaccine Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Livestock Animal Vaccine Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Livestock Animal Vaccine Market (2019-2035)
  • Table 11.1: Product Mapping of Livestock Animal Vaccine Suppliers Based on Segments
  • Table 11.2: Operational Integration of Livestock Animal Vaccine Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Livestock Animal Vaccine Revenue
  • Table 12.1: New Product Launches by Major Livestock Animal Vaccine Producers (2019-2026)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Livestock Animal Vaccine Market